Last update 01 Nov 2024
Max-Delbrück-Centrum für Molekulare Medizin (MDC)

Max-Delbrück-Centrum für Molekulare Medizin (MDC)

Private Company|
1992|
Germany
|
1,000-5,000
|

Overview

Basic Info

Introduction
The Max Delbrück Center for Molecular Medicine, located in Berlin, is a member of the Helmholtz Association of German Research Centres and was established in 1992 as the successor to the Zentralinstitut für Molekularbiologie. The center is named after the Nobel prize-winning scientist Max Delbrück, who was born in Berlin. The institute focuses on basic research in molecular biology, while also conducting clinical research in three key areas: cardiovascular and metabolic diseases, cancer research, and the function and dysfunction of the nervous system.

Tags

Immune System Diseases
Hemic and Lymphatic Diseases
Respiratory Diseases
Small molecule drug
TCR therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug2
TCR therapy1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Preclinical
Phase 2 Clinical
1
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MDG-1011
( PRAME )
Myelodysplastic Syndromes
More
Phase 2
CL-27c
( PI3Kα )
Asthma
More
Preclinical
PITCOIN4
( PIK3C2A )
-
Discovery
CJM-216
Breast Cancer
More
Pending
LF-3
( CTNNB1 x Wnt )
Neoplasms
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free